Advanced Accelerator Applications S.A. [•] Ordinary Shares (nominal value €0.10 per share) Represented by [•] American Depositary Shares Underwriting AgreementUnderwriting Agreement • January 20th, 2015 • Advanced Accelerator Applications S.A. • Pharmaceutical preparations • New York
Citigroup Global Markets Inc. Jefferies LLC As Representatives of the several Underwriters, c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013
Agreement on Special Compensation allowanceSpecial Compensation Agreement • January 20th, 2015 • Advanced Accelerator Applications S.A. • Pharmaceutical preparations
Advanced Accelerator Applications S.A., a joint-stock company (société anonyme) incorporated under the laws of France, with registered office in 20, rue Diesel-01630 – Saint Genis Pouilly (France), with share capital of Euro 6.322.904,10 € fully paid-in (the “Company”)
LICENSE AGREEMENTLicense Agreement • January 20th, 2015 • Advanced Accelerator Applications S.A. • Pharmaceutical preparations
This Agreement, executed this 12th day of June, 2007, ("the Effective Date") is made by and between Professor Dr. Eric P. Krenning, Hoflaan 71, 3062 Je Rotterdam, The Netherlands ("Krenning"), and BioSynthema Inc., a corporation organized under the laws of the State of Missouri, USA, and having its principal place of business 4041 Forest Park Blvd., S1. Louis, Missouri, 63108 USA ("BioSynthema"), and hereafter referred to as the "Agreement". For the purpose of the Agreement, BioSynthema shall include a sublicensee to the Agreement.
